Share and Cite: Hinz, B. and Kenyon, J. (2025) Getting to a Diagnosis: A Rare Case of TFE3 Translocation Renal Cell Carcinoma ...

Impact of time to surgery on outcomes in patients with advanced esophageal squamous cell carcinoma following neoadjuvant therapy: An exploratory analysis of phase III trial JCOG1109. This is an ASCO ...

Keytruda (pembrolizumab) plus Lenvima (lenvatinib) and chemotherapy improved progression-free survival but did not achieve statistical significance for overall survival in patients with advanced ...

The CHMP recommends approval of Bristol Myers' Opdivo plus Yervoy for the first-line treatment of hepatocellular carcinoma ...

The best multimodal approach for resectable locally advanced esophageal adenocarcinoma is unclear ... Radical locoregional lower mediastinal and abdominal lymph-node dissection was mandatory.

The company announced interim data showing strong systemic responses in its safety and efficacy study combining Alpha DaRT treatment with ...

On World Cancer Day, Mamta Mohandas, Yuvraj Singh, Lisa Ray, and others inspire with their cancer survival stories.

High disease control rate and strong interim safety results observed in pancreatic cancer patients across three trials exploring the use of ...

We present a case of a 50-year-old patient who developed mediastinal and hilar lymphadenopathy during adjuvant pembrolizumab therapy following nephrectomy for stage III RCC, which was initially ...

The lymph nodes in the cervical, mediastinal, periaortic ... The finding of a diffuse bronchogenic carcinoma as the stimulus for the widespread osteoblastic metastases is in itself unusual.